Publikationen in Zusammenarbeit mit Forschern von Pfizer (United States) (16)

2023

  1. Medical consultation in ulcerative colitis: Key elements for improvement

    World Journal of Gastroenterology, Vol. 29, Núm. 6, pp. 917-925

2022

  1. Adherence improvement in patients with ulcerative colitis: a multidisciplinary consensus document

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 3, pp. 156-165

  2. Cost-effectiveness analysis of using innovative therapies for the management of moderate-to-severe ulcerative colitis in Spain

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 22, Núm. 1, pp. 73-83

2021

  1. Management of particular clinical situations in psoriatic arthritis: an expert’s recommendation document based on systematic literature review and extended Delphi process

    Rheumatology International, Vol. 41, Núm. 9, pp. 1549-1565

  2. Patient Journey in Atopic Dermatitis: The Real-World Scenario

    Dermatology and Therapy, Vol. 11, Núm. 5, pp. 1693-1705

  3. Update on the Safety Profile of Tofacitinib in Rheumatoid Arthritis from Clinical Trials to Real-World Studies: A Narrative Review

    Rheumatology and Therapy, Vol. 8, Núm. 1, pp. 17-40

2020

  1. Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain

    Clinical Rheumatology, Vol. 39, Núm. 10, pp. 2919-2930

  2. Delphi-based recommendations for the management of cardiovascular comorbidities in patients with psoriatic arthritis and moderate-to-severe psoriasis

    Rheumatology International, Vol. 40, Núm. 6, pp. 969-981

  3. Disease features associated with a low disease impact in patients with psoriatic arthritis: Results of a cross-sectional multicenter study

    Arthritis Research and Therapy, Vol. 22, Núm. 1

  4. Gaps between research and recommendations in rheumatoid arthritis

    Rheumatology International

2019

  1. Consensus Statement on the Psychological Needs of Patients With Chronic Inflammatory Skin Diseases

    Actas Dermo-Sifiliograficas, Vol. 110, Núm. 2, pp. 102-114

  2. Economic Impact of Etanercept in Patients with Psoriasis and Psoriatic Arthritis in Spain: A Systematic Review

    Dermatology and Therapy, Vol. 9, Núm. 3, pp. 479-496

  3. Very low disease activity, DAPSA remission, and impact of disease in a Spanish population with psoriatic arthritis

    Journal of Rheumatology, Vol. 46, Núm. 7, pp. 710-715

2018

  1. Effects of etanercept on the patient-perceived results (PROs) in patients with moderate-to-severe plaque psoriasis: systematic review of the literature and meta-analysis

    Journal of Dermatological Treatment, Vol. 29, Núm. 8, pp. 806-811

  2. Expert recommendations on the psychological needs of patients with rheumatoid arthritis

    Rheumatology International, Vol. 38, Núm. 12, pp. 2167-2182

2017

  1. Minimal disease activity and impact of disease in psoriatic arthritis: A Spanish cross-sectional multicenter study

    Arthritis Research and Therapy, Vol. 19, Núm. 1